[{"@context":"https://schema.org","@type":"JobPosting","title":"QC Analyst II/III Reviewer (Contract)","description":"

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies designed to be delivered in physicians’ offices to eliminate the need for frequent ocular injections to treat these diseases. By overcoming the challenges associated with current treatment paradigms for these debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe.

Note to Recruiters and Agencies
All recruiter and agency inquiries must go through Adverum’s internal Talent Acquisition team. Unsolicited resumes sent to Adverum will be considered Adverum's property. Adverum’s Talent Acquisition team must expressly engage agencies for any requisition. Direct contact with hiring managers by agencies will not be tolerated and may affect your ability to work with Adverum in the future.

Adverum is seeking a dedicated Quality Control Analyst to be a part of our vibrant team based in our Redwood City office. Reporting variably to the Quality Control Manager, Quality Control Lead, or as a part of a project hierarchy, this role will engage collaboratively with the QC team and other cross-functional teams. As a vital member of the Quality Control unit, the analyst will play a significant role in advancing and performing Quality Control (QC) review of different assay techniques, systems, policies, processes, procedures, and controls pertinent to the analytical examination ","datePosted":"2026-05-28","employmentType":"CONTRACTOR","hiringOrganization":{"@type":"Organization","name":"Adverum"},"url":"https://jobs.lever.co/adverum/39680397-a63b-4e87-98ac-f1c67ad1091b","jobLocation":{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Redwood City, CA"}}},{"@context":"https://schema.org","@type":"JobPosting","title":"Principal Scientist, Downstream Process Development (Contract) - AW","description":"

Adverum is looking for a Principal Scientist, Downstream Process Development to join the Process Development team at our Redwood City, CA office. The individual will be part of the team responsible for developing and optimizing the downstream process development activities for adeno-associated virus (AAV) gene therapy programs. The successful candidate will participate in late-stage activities including design and optimization of the process as needed using historical batch data and manufacturing needs; process characterization; and tech-transfer of downstream processes to support clinical and commercial manufacturi","datePosted":"2026-04-24","employmentType":"CONTRACTOR","hiringOrganization":{"@type":"Organization","name":"Adverum"},"url":"https://jobs.lever.co/adverum/0f479774-9640-4402-959a-c0cbb0456133","jobLocation":{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Redwood City, CA"}}},{"@context":"https://schema.org","@type":"JobPosting","title":"Director, QA Systems (Contract)","description":"

Adverum Biotechnologies, Inc., a wholly owned subsidiary of Eli Lilly and Company is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies designed to be delivered in physicians’ offices to eliminate the need for frequent ocular injections to treat these diseases. By overcoming the challenges associated with current treatment paradigms for these debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe.

Note to Recruiters and Agencies

All recruiter and agency inquiries must go through Adverum’s internal Talent Acquisition team. Unsolicited resumes sent to Adverum will be considered property of Adverum. Agencies must be expressly engaged by Adverum’s Talent Acquisition team for any requisition. Direct contact with hiring managers by agencies will not be tolerated and may affect your ability to work with Adverum in the future.

The Director of QA Systems is responsible for optimizing Quality systems to ensure adherence to late-stage clinical and commercial multi-regional regulatory requirements, as well as corporate quality objectives. The candidate will have demonstrated successful development, implementation, and execution of robust Quality systems and processes covering CMC, Clinical, Regulatory, and IT functions.

The individual must provide strategic leadership within internal and external CMC functions, along with cross-functional leadership at Eli Lilly, ensuring a successful integration process. This in","datePosted":"2026-02-17","employmentType":"CONTRACTOR","hiringOrganization":{"@type":"Organization","name":"Adverum"},"url":"https://jobs.lever.co/adverum/9d013f01-6a7a-46e5-989f-3a98432f16c5","jobLocation":{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Redwood City, CA"}}},{"@context":"https://schema.org","@type":"JobPosting","title":"Work with us!","description":"

Adverum is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the capabilities of its proprietary intravitreal platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. Additionally, by overcoming the challenges associated with current treatment paradigms for debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe.

Note to Recruiters and Agencies

At Adverum, we’re always excited to meet people who share our mission. If you don’t see a role that fits today, share your details—we’re always looking to connect with those who believe that great science starts with great people.

","datePosted":"2020-10-29","employmentType":"FULL_TIME","hiringOrganization":{"@type":"Organization","name":"Adverum"},"url":"https://jobs.lever.co/adverum/2a92e0c0-4a8d-44f0-b039-25d4d27fda94","jobLocation":{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Redwood City, CA"}}}]

Adverum

Open roles4